The article for PMLiVE and Pharmaceutical Market Europe focuses on the transformations that data management and technology are bringing to the healthcare system, especially clinical research. Improvements in technology reduce errors and increase the immediacy and quality of data and researchers are better able to visualise patterns and trends, granting a real-time assessment of the safety of patients and trajectory of a trial. This aids medical decision-making and ensures more efficient studies.

 

Other improvements include the incorporation of Real-World Data and AI, which could save time and resources within trials. These advances support improved drug development and treatments being accepted into the market faster, ultimately benefitting patients. Regulators are adapting to these changes too, and are setting updated and clear criteria for the type of evidence they will accept during early-phase clinical research.

 

Continued advances in data management and data science will ensure that the general population will be able to benefit from new life-saving medications developed and integrated into the market faster and cheaper thanks to advances in data management.

 

To read the full article, click here

Latest news

Richmond Pharmacology Announces Promotions of Dr Matej Goricar and Dr Amir Majid

December 1, 2024
Richmond is pleased to announce the promotions of Dr Matej Goricar and Dr Amir Majid to senior roles within the Medical Directorate as Associate Medical Directors.
Read more

Richmond trains taxi drivers to deliver lifesaving CPR

December 3, 2024
Richmond has just trained a first group of taxi drivers to deliver cardiopulmonary resuscitation (CPR) aimed at saving the lives of their passengers.
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event